Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum
暂无分享,去创建一个
Norbert Schuff | Michael W. Weiner | William Jagust | Duygu Tosun | N. Schuff | M. Weiner | W. Jagust | D. Tosun
[1] Felice Sun,et al. Brain imaging evidence of preclinical Alzheimer's disease in normal aging , 2006, Annals of neurology.
[2] Daniel Rueckert,et al. Random forest-based similarity measures for multi-modal classification of Alzheimer's disease , 2013, NeuroImage.
[3] S. Wold,et al. Multi‐way principal components‐and PLS‐analysis , 1987 .
[4] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[5] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[6] S. Laughlin,et al. An Energy Budget for Signaling in the Grey Matter of the Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] Sven Haller,et al. Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. , 2015, Radiology.
[8] Jeffrey A. Fessler,et al. Reducing between scanner differences in multi-center PET studies , 2009, NeuroImage.
[9] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[10] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[11] et al.,et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.
[12] Hengyi Rao,et al. Applications of arterial spin labeled MRI in the brain , 2012, Journal of magnetic resonance imaging : JMRI.
[13] Jerry L Prince,et al. Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] A. Drzezga,et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[15] D. Knopman,et al. Vascular risk factors: imaging and neuropathologic correlates. , 2010, Journal of Alzheimer's disease : JAD.
[16] Rachel L. Mistur,et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[17] J. Detre,et al. Assessment of cerebral blood flow in Alzheimer's disease by spin‐labeled magnetic resonance imaging , 2000, Annals of neurology.
[18] J. Detre,et al. Perfusion magnetic resonance imaging with continuous arterial spin labeling: methods and clinical applications in the central nervous system. , 1999, European journal of radiology.
[19] Mark E. Schmidt,et al. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[20] S. Santi,et al. Hippocampal hypometabolism predicts cognitive decline from normal aging , 2008, Neurobiology of Aging.
[21] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[22] P. Magistretti,et al. Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[23] M. Raichle. Behind the scenes of functional brain imaging: a historical and physiological perspective. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] M. Mintun,et al. Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods , 2013, The Journal of Nuclear Medicine.
[25] Janet S. Reddin,et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.
[26] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[27] M. Jüptner,et al. Review: Does Measurement of Regional Cerebral Blood Flow Reflect Synaptic Activity?—Implications for PET and fMRI , 1995, NeuroImage.
[28] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] Mayank A. Jog,et al. Regional Correlation between Resting State FDG PET and pCASL Perfusion MRI , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] N. Schuff,et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.
[31] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[32] C Crouzel,et al. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[34] Simultaneous Measurement of Local Glucose Utilization and Blood Flow in the Rat Brain: An Autoradiographic Method Using Two Tracers Labeled with Carbon-14 , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] Mark E. Schmidt,et al. The Alzheimer’s Disease Neuroimaging Initiative: A review of papers published since its inception , 2012, Alzheimer's & Dementia.
[36] A. Hofman,et al. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam study , 2005, Annals of neurology.
[37] M. Mintun,et al. Nonoxidative glucose consumption during focal physiologic neural activity. , 1988, Science.
[38] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[39] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[40] Janet S. Reddin,et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease , 2011, Neurology.
[41] George A. Carlson,et al. Alterations in Cerebral Blood Flow and Glucose Utilization in Mice Overexpressing the Amyloid Precursor Protein , 2002, Neurobiology of Disease.